(Q33155805)

22 July 2017

1 reference

title

Cardiac side effects of psychiatric drugs (English)

1 reference

22 July 2017

Paul Mackin

1

1 reference

22 July 2017

1 January 2008

1 reference

22 July 2017

Human Psychopharmacology

1 reference

22 July 2017

23 Suppl 1

1 reference

22 July 2017

3-14

1 reference

Medical comorbidity in schizophrenia

22 July 2017

1 reference

Torsade de pointes associated with very-high-dose methadone

21 January 2018

1 reference

Relationship between utilization of mental health and medical services in a VA hospital

21 January 2018

1 reference

Drug induced QT prolongation and torsades de pointes

21 January 2018

1 reference

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine

21 January 2018

1 reference

7 January 2021

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia

1 reference

7 January 2021

Guidelines on management (diagnosis and treatment) of syncope.

1 reference

7 January 2021

Causes of the excess mortality of schizophrenia

1 reference

7 January 2021

Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report

1 reference

7 January 2021

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

7 January 2021

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study

1 reference

7 January 2021

Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

1 reference

7 January 2021

QT prolongation and sudden cardiac death in patients with alcoholic liver disease

1 reference

7 January 2021

Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study

1 reference

7 January 2021

Prolongation of QT interval in isolated feline hearts by antipsychotic drugs

1 reference

7 January 2021

Integrated medical care for patients with serious psychiatric illness: a randomized trial.

1 reference

7 January 2021

Serious cardiovascular events and mortality among patients with schizophrenia

1 reference

7 January 2021

A review of clozapine safety

1 reference

7 January 2021

Recent evidence linking coronary heart disease and depression

1 reference

7 January 2021

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls

1 reference

7 January 2021

Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham Heart Study experience).

1 reference

7 January 2021

Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes

1 reference

7 January 2021

Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003

1 reference

7 January 2021

Life expectancies for individuals with psychiatric diagnoses

1 reference

7 January 2021

Differential metabolic effects of antipsychotic treatments

1 reference

7 January 2021

Electrocardiographic abnormalities in patients treated with clozapine

1 reference

7 January 2021

Myocarditis and cardiomyopathy associated with clozapine

1 reference

7 January 2021

Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease

1 reference

7 January 2021

Haloperidol-induced torsades de pointes

1 reference

7 January 2021

Myocarditis and cardiomyopathy associated with clozapine use in the United States

1 reference

7 January 2021

Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate

1 reference

7 January 2021

The health of the chronically mentally ill: a review of the literature

1 reference

7 January 2021

QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: a preliminary study

1 reference

7 January 2021

Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study

1 reference

7 January 2021

Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community.

1 reference

7 January 2021

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

1 reference

7 January 2021

Adverse cardiac effects associated with clozapine

1 reference

7 January 2021

Myocarditis during clozapine treatment

1 reference

7 January 2021

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

7 January 2021

Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database

1 reference

7 January 2021

QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients

1 reference

7 January 2021

Thioridazine and sudden unexplained death in psychiatric in-patients.

1 reference

7 January 2021

Myocarditis with quetiapine

1 reference

7 January 2021

QT interval prolongation predicts cardiovascular mortality in an apparently healthy population

1 reference

7 January 2021

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

7 January 2021

Tolerability of atypical antipsychotics

1 reference

7 January 2021

Torsades de pointes associated with drugs and toxins: recognition and management

1 reference

7 January 2021

Antipsychotics and QT prolongation

1 reference

7 January 2021

Clozapine-induced fevers and 1-year clozapine discontinuation rate.

1 reference

7 January 2021

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

7 January 2021

Electrocardiographic changes in patients receiving neuroleptic medication.

1 reference

7 January 2021

Clozapine and sudden death

1 reference

7 January 2021

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.915

1 reference

22 July 2017

1 reference

PubMed ID

18098218